Table 2 COVID-19 regimen used during admission
Intervention or medication | DPP4i (n = 166) | Non-DPP4i (n = 351) | p-value |
|---|---|---|---|
Medications used during admission | |||
IV steroids | 82 (49.4) | 211 (60.1) | 0.022 |
Favipiravir | 24 (14.5) | 49 (14.0) | 0.879 |
Tocilizumab | 15 (9.0) | 35 (10.0) | 0.737 |
Hydroxychloroquine | 21 (12.7) | 26 (7.4) | 0.053 |
Remdesivir | 1 (0.6) | 15 (4.3) | 0.024 |
lopinavir/ritonavir | 7 (4.2) | 3 (0.9) | 0.010 |
Ribavirin | 4 (2.4) | 4 (1.1) | 0.275 |
Interferon B | 1 (0.6) | 2 (0.6) | 1.000 |
Oxygenation requirement upon admission | < 0.001 | ||
No oxygenation | 69 (41.6) | 121 (34.5) | |
Non-invasive oxygenation requirements | 87 (52.4) | 164 (46.7) | |
Invasive oxygenation requirements | 10 (6.0) | 66 (18.8) |